803
Views
5
CrossRef citations to date
0
Altmetric
Review

Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?

, &
Pages 59-82 | Received 29 Jun 2016, Accepted 07 Dec 2017, Published online: 18 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jinmeng Li, Xinjun Cai, Yueting Chen, Chenyu Wang & Zheng Jiao. (2023) Parametric population pharmacokinetics of isoniazid: a systematic review. Expert Review of Clinical Pharmacology 16:5, pages 467-489.
Read now
Tesemma Sileshi, Gosaye Mekonen, Eyasu Makonnen & Eleni Aklillu. (2022) Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review. Pharmacogenomics and Personalized Medicine 15, pages 561-571.
Read now
David W. Hein & Lori M. Millner. (2021) Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review. Expert Opinion on Drug Metabolism & Toxicology 17:1, pages 9-21.
Read now
Linsheng Liu, Xianglian Li, Chenrong Huang, Yicong Bian, Xiaoxue Liu, Jun Cao, Wenhao Qu & Liyan Miao. (2020) Bile acids, lipid and purine metabolism involved in hepatotoxicity of first-line anti-tuberculosis drugs. Expert Opinion on Drug Metabolism & Toxicology 16:6, pages 527-537.
Read now
Giuseppe Miscio, Giulia Paroni, Paola Bisceglia, Carolina Gravina, Maria Urbano, Madia Lozupone, Carla Piccininni, Michele Prisciandaro, Grazia Ciavarella, Antonio Daniele, Antonello Bellomo, Francesco Panza, Lazzaro Di Mauro, Antonio Greco & Davide Seripa. (2019) Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 751-765.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.